Filing Flows › CV Sciences (CVSI) › Q2 2026
CV Sciences (CVSI) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 13, 2026
CV Sciences (CVSI) reported revenue of $3.0M for the second quarter 2026 (Q2 2026), -18% from a year earlier and -7% from the quarter before. Operating margin was -10.1%, net loss $775K (26.0% of revenue).
CV Sciences, Q2 2026: revenue $3.0M (-18% year over year), operating margin -10.1%, net loss $775K, operating cash flow $20K. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.0M | -7% | -18% |
| Operating profit | −$301K | — | — |
| Net earnings | −$775K | — | — |
| Operating cash flow | $20K | -80% | -93% |
| Free cash flow | $13K | -87% | -95% |
What changed
Revenue was $3.0M in Q2 2026, down 18% year over year and down 7% from the previous quarter.
Gross margin was 48.6%, down 2.4 points from Q2 2025. Operating costs exceeded revenue by $301K, an operating margin of -10.1%. Operating expenses fell 11% while revenue fell 18%. The quarter ended with a net loss of $775K, wider than the previous quarter's $643K loss. Net interest and other expense of $469K was the main reason.
Operating cash flow was $20K (down 93% year over year). Non-cash charges added back $22K of depreciation and amortization and $148K of share-based compensation. Working capital and other items added $625K. Capital expenditures of $7K left free cash flow of $13K.
Questions
What was CV Sciences' revenue in the second quarter 2026?
CV Sciences (CVSI) reported revenue of $3.0M for the second quarter 2026 (Q2 2026), -18% from a year earlier and -7% from the quarter before.
Was CV Sciences profitable in the second quarter 2026?
Operating loss was $301K (-10.1% of revenue) and net loss $775K.
Source: CV Sciences 10-Q on SEC EDGAR.